orders@qcsrm.com | +86 755-6685 3366 | 2851296953 | 13670046396

LOG IN REGISTER CART(0) 中文
  • HOME
  • PRODUCTS
  • SERVICES
  • WHY QCS
  • FAQ
  • NEWS & BLOGS
  • CONTACT US
    • NEWS & BLOGS
    NEWS & BLOGS

    Search on NEWS & BLOGS

    Archives Timeline

    Search on NEWS & BLOGS

    Archives Timeline

    2024-11-15

    2024V32 | Exploration of the stability of Eltrombopag impurity reference standar...
    Today, we share a new generation of platelet receptor agonist - the stability study of specific impurities of Eltrombopag. Eltrombopag is a new generation of platelet receptor agonist, and its main fu[...]

    2024-11-08

    2024V31 | Stability Studies of Specific Impurities in Ibuprofen: A Focus on Nons...
    Today, we present the stability study of ibuprofen-specific impurities in NSAIDs. Ibuprofen is classified as a non-steroidal anti-inflammatory drug (NSAID) primarily utilized for alleviating mild to m[...]

    2024-11-01

    2024V29 | Stability Study of Specific Impurities in the Anticoagulant Drug Rivar...
    IntroductionIn this study, we present an analysis of the stability of specific impurities in Rivaroxaban, a highly selective and dose-dependent novel oral anticoagulant. This agent exerts its anticoag[...]

    2024-10-23

    2024V28 | Sharing research on the stability of Antitumor drug-Ruxolitinib Phosph...
    IntroductionToday, we will share the research on the stability of Antitumor drug-Ruxolitinib specific impurities. Ruxolitinib is an antitumor drug that has good therapeutic effects on tumor disea[...]

    2024-10-14

    2024V27 | Stability Study of Specific Impurities in the Antipsychotic Drug Brexp...
    Introduction Today, we present a stability study on the specific impurities of the atypical antipsychotic drug Epiprazole (briprazole). Epiprazole (briprazole) is classified as an atypical antips[...]

    2024-10-10

    2024V26 | Stability Study of Specific Impurities in the JAK Inhibitor Upadacitin...
    Introduction This study presents the stability of specific impurities in Upatinib, a selective JAK inhibitor designed for the treatment of refractory moderate-to-severe atopic dermatitis in adult[...]

    2024-10-09

    2024V25 | Stability Study of Specific Impurities in Dapoxetine for the Treatment...
    Introduction Today, we present a study on the stability of specific impurities in Dapoxetine, a pharmacological treatment for premature ejaculation (PE) in men aged 18 to 64 years who experi[...]

    2024-09-27

    2024V24 | Development of Thermal Degradation Impurities of Isavuconazole Sulfate...
    Introduction Isavuconazonium sulfate is a novel therapeutic agent for the management of invasive aspergillosis and invasive mucormycosis in adult patients. This drug was collaboratively developed by B[...]

    2024-09-20

    2024V23 | Sharing research on the stability of Antithrombotic drug-Apixaban spec...
    Today, we will share a study on the stability of Antithrombotic drug-Apixaban specific impurities. Apixaban is clinically used in adult patients undergoing hip or knee replacement surgery to prevent v[...]

    2024-09-13

    2024V22 | Sharing research on the stability of anti gastric acid medication - Vo...
     IntroductionToday, we will share the stability study of specific impurities in reversible proton pump inhibitors-Vonoprazan. Vonoprazan is a reversible proton pump inhibitor with advantages such[...]

    2024-11-15

    2024V32 | Exploration of the stability of Eltrombopag impurity reference standar...
    Today, we share a new generation of platelet receptor agonist - the stability study of specific impurities of Eltrombopag. Eltrombopag is a new generation of platelet receptor agonist, and its main function is [...]

    2024-11-08

    2024V31 | Stability Studies of Specific Impurities in Ibuprofen: A Focus on Nons...
    Today, we present the stability study of ibuprofen-specific impurities in NSAIDs. Ibuprofen is classified as a non-steroidal anti-inflammatory drug (NSAID) primarily utilized for alleviating mild to moderate pa[...]

    2024-11-01

    2024V29 | Stability Study of Specific Impurities in the Anticoagulant Drug Rivar...
    IntroductionIn this study, we present an analysis of the stability of specific impurities in Rivaroxaban, a highly selective and dose-dependent novel oral anticoagulant. This agent exerts its anticoagulant effe[...]

    2024-10-23

    2024V28 | Sharing research on the stability of Antitumor drug-Ruxolitinib Phosph...
    IntroductionToday, we will share the research on the stability of Antitumor drug-Ruxolitinib specific impurities. Ruxolitinib is an antitumor drug that has good therapeutic effects on tumor diseases caused[...]

    2024-10-14

    2024V27 | Stability Study of Specific Impurities in the Antipsychotic Drug Brexp...
    Introduction Today, we present a stability study on the specific impurities of the atypical antipsychotic drug Epiprazole (briprazole). Epiprazole (briprazole) is classified as an atypical antipsychotic th[...]

    2024-10-10

    2024V26 | Stability Study of Specific Impurities in the JAK Inhibitor Upadacitin...
    Introduction This study presents the stability of specific impurities in Upatinib, a selective JAK inhibitor designed for the treatment of refractory moderate-to-severe atopic dermatitis in adults and adol[...]

    2024-10-09

    2024V25 | Stability Study of Specific Impurities in Dapoxetine for the Treatment...
    Introduction Today, we present a study on the stability of specific impurities in Dapoxetine, a pharmacological treatment for premature ejaculation (PE) in men aged 18 to 64 years who experience signi[...]

    2024-09-27

    2024V24 | Development of Thermal Degradation Impurities of Isavuconazole Sulfate...
    Introduction Isavuconazonium sulfate is a novel therapeutic agent for the management of invasive aspergillosis and invasive mucormycosis in adult patients. This drug was collaboratively developed by Basilea Pha[...]

    2024-09-20

    2024V23 | Sharing research on the stability of Antithrombotic drug-Apixaban spec...
    Today, we will share a study on the stability of Antithrombotic drug-Apixaban specific impurities. Apixaban is clinically used in adult patients undergoing hip or knee replacement surgery to prevent venous thro[...]

    2024-09-13

    2024V22 | Sharing research on the stability of anti gastric acid medication - Vo...
     IntroductionToday, we will share the stability study of specific impurities in reversible proton pump inhibitors-Vonoprazan. Vonoprazan is a reversible proton pump inhibitor with advantages such as faster[...]

    Join Our Email List

    Subscribe to receive updates on new
    products, promotions and resources!

    Join Our Email List

    Subscribe to receive updates on new
    products, promotions and resources!

    NEED HELP ?
    Tel: +86 755-66853366
    Fax: +86 755-28363542
    orders@qcsrm.com
    www.qcsrm.com
    COA Sample
    National High-tech Enterprise
    QUALITY CONTROL SOLUTIONS LTD.
    B3-301A,401,402 Life Science Park
    SCT Creative Factory, Pingshan District
    ShenZhen, China
    ISO 17034:2016
    ISO 9001:2015
    Statutory Pharmacopoeia
    FOLLOW US

    *All our products are for R&D.

    NEED HELP ?
    Tel: +86 755-66853366
    Fax: +86 755-28363542
    orders@qcsrm.com
    www.qcsrm.com
    QUALITY CONTROL SOLUTIONS LTD.
    B3-301A,401,402 Life Science Park
    SCT Creative Factory, Pingshan District
    ShenZhen, China
    COA Sample
    National High-tech Enterprise
    ISO 17034:2016
    ISO 9001:2015
    Statutory Pharmacopoeia
    FOLLOW US

    *All our products are for R&D.

    Copyright © 2021-2024 QCSRM All rights reserved. 粤ICP备2023004355号

    Copyright © 2021-2024 QCSRM All rights reserved.
    粤ICP备2023004355号

    0.0326s